Stem cell therapy for neurodegenerative diseases

Neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS), have long been a challenge for medical science due to their progressive and debilitating nature. With an increasing aging population, the prevalence of these diseases is rising, particularly in India. According to a report by the Alzheimer's and Related Disorders Society of India (ARDSI), over 4 million people in India suffer from some form of dementia. Similarly, the Parkinson’s Disease Foundation estimates that nearly 1 million people in India are affected by Parkinson’s disease.
Stem cell therapy, a revolutionary approach in regenerative medicine, offers new hope for treating these conditions. This article delves into the potential of stem cell therapy for neurodegenerative diseases, its availability in India and its approval status by the FDA.